GERI-KOT- standardized senna concentrate tablet

Land: Bandaríkin

Tungumál: enska

Heimild: NLM (National Library of Medicine)

Virkt innihaldsefni:

SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX)

Fáanlegur frá:

Geri-Care Pharmaceutical Corp

Stjórnsýsluleið:

ORAL

Gerð lyfseðils:

OTC DRUG

Ábendingar:

Laxative - relieves occasional constipation (irregularity) - generally produces bowel movement in 6 to 12 hours

Leyfisstaða:

OTC monograph not final

Vara einkenni

GERI-KOT- STANDARDIZED SENNA CONCENTRATE TABLET
GERI-CARE PHARMACEUTICAL CORP
----------
GC 454
ACTIVE INGREDIENT (IN EACH TABLET)
Sennosides 8.6 mg
PURPOSE
Laxative
USES
relieves occasional constipation (irregularity)
generally produces bowel movement in 6 to 12 hours
WARNINGS
DO NOT USE
for more than 1 week unless directed by a doctor.
ASK A DOCTOR BEFORE USE IF YOU
have abdominal pain, nausea or vomiting
have noticed a sudden change in bowel habits that lasts over 2 weeks
STOP USE AND ASK A DOCTOR IF you have rectal bleeding or fail to
have a bowel movement after use of a laxative.
These may indicate a serious condition .
IF PREGNANT OR BREAST-FEEDING,
ask a health professional before use.
KEEP OUT OF REACH OF CHILDREN. In case of overdose, get medical help
or contact a
Poison Control Center right away.
DIRECTIONS
• do not exceed 8 tablets in 24 hours
AGE
STARTING DOSE
MAXIMUM DOSE
adults and children
12 years of age and
older
2 tablets once a day preferably at
bedtime; increase as needed, or as
directed by a doctor
4 tablets in the
morning and 4 tablets
at bedtime
children under 12
children under 12
years
ask a doctor
OTHER INFORMATION
EACH TABLET CONTAINS: calcium 40 mg
TAMPER EVIDENT: Do not use if imprinted seal under cap is missing or
broken
store at room temperature
INACTIVE INGREDIENTS
cellulose, croscarmellose sodium,
dicalcium phosphate, hypromellose*, magnesium silicate*,
magnesium stearate, mineral oil*, PEG*, silica*, wax*.
*May contain these ingredients
PACKAGE LABEL
GERI-KOT
standardized senna concentrate tablet
PRODUCT INFORMATION
PRODUCT TYPE
HUMAN OTC DRUG
ITEM CODE (SOURCE)
NDC:57896-454
ROUTE OF ADMINISTRATION
ORAL
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRENGTH
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX)
SENNOSIDES
8.6 mg
Geri-Care Pharmaceutical Corp
INACTIVE INGREDIENTS
INGREDIENT NAME
STRENGTH
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
CALCIUM PHOSPHATE, DIBASIC,